Cellecta at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Cellecta brings 2 presentations to AMP 2026 in Seattle, and exhibits at Booth 2205. Its sessions cover workflows for mapping antigen-specific T-cell and B-cell clonotypes, and how those clonotypes feed receptor-based target and biomarker discovery. The company supplies genomic products and services including viral vectors, functional screening and multiplex qRT-PCR.
| Organization | AMP 2026 Attendance |
|---|---|
Cellecta Mountain View, CA | |
Genomic products and services for drug target and biomarker discovery: viral vector production, functional screening, cell engineering and multiplex qRT-PCR. | Booth Exhibiting at Booth 2205 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 2:00pm–2:50pm From Repertoire to Response: A Workflow for Mapping Antigen-Specific T- and B-Cell Clonotypes for Receptor-Based Target Discovery Pairing immune receptor sequencing with antigen screening to rank tumour-specific T- and B-cell clonotypes, including from plasma. Workshop Sat, Nov 14 9:30am–10:00am Discovery and Validation of T- and B-Cell Clonotypes to Drive Next-Level Drug and Biomarker Discovery An end-to-end route from bulk and single-cell receptor sequencing to screening that surfaces drug and biomarker candidates. |
Instantly find 20 buyers from Cellecta
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction